These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18801635)

  • 1. Metrologic approaches to setting acceptance criteria: unacceptable and unusual characteristics.
    Hauck WW; Abernethy DR; Williams RL
    J Pharm Biomed Anal; 2008 Nov; 48(3):1042-5. PubMed ID: 18801635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical method transfer: new descriptive approach for acceptance criteria definition.
    de Fontenay G
    J Pharm Biomed Anal; 2008 Jan; 46(1):104-12. PubMed ID: 17961955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance criteria for method equivalency assessments.
    Chatfield MJ; Borman PJ
    Anal Chem; 2009 Dec; 81(24):9841-8. PubMed ID: 19925004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2011; (961):1-428, back cover. PubMed ID: 21699061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2009; (953):1-161. PubMed ID: 19621561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of analytical procedures: a panel of strategies selected for risk management, with emphasis on an integrated equivalence-based comparative testing approach.
    Agut C; Caron A; Giordano C; Hoffman D; Ségalini A
    J Pharm Biomed Anal; 2011 Sep; 56(2):293-303. PubMed ID: 21700410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance criteria for levels of hydrazine in substances for pharmaceutical use and analytical methods for its determination.
    Kean T; Miller JH; Skellern GG; Snodin D
    Pharmeur Sci Notes; 2006 Dec; 2006(2):23-33. PubMed ID: 17691211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacopoeia--a mirror of the development of pharmaceutical sciences and socialist health service].
    Kny L
    Cesk Farm; 1977 Dec; 26(10):441-5. PubMed ID: 612365
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding Quality Paradigm Shifts in the Evolving Pharmaceutical Landscape: Perspectives from the USP Quality Advisory Group.
    Weitzel J; Pappa H; Banik GM; Barker AR; Bladen E; Chirmule N; DeFeo J; Devine J; Emrick S; Hout TK; Levy MS; Mahlangu GN; Rellahan B; Venema J; Workman W
    AAPS J; 2021 Oct; 23(6):112. PubMed ID: 34654974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information chapters in pharmacopoeias.
    Banes D
    Ann Ist Super Sanita; 1975; 11(3-4):290-5. PubMed ID: 1234730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality.
    O'Connor TF; Yu LX; Lee SL
    Int J Pharm; 2016 Jul; 509(1-2):492-498. PubMed ID: 27260134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010).
    Schepers U; Wätzig H
    J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach.
    Vergote V; Burvenich C; Van de Wiele C; De Spiegeleer B
    J Pept Sci; 2009 Nov; 15(11):697-710. PubMed ID: 19750489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.